Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Protein Networks02:26

Protein Networks

4.0K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.0K
Protein-Protein Interfaces02:04

Protein-Protein Interfaces

3.8K
3.8K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

523
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
523
Ligand Binding Sites02:40

Ligand Binding Sites

12.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.9K
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

47
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
47

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A(C)VPpred: Transfer Learning-Enhanced Prediction of Antiviral and Anticoronavirus Peptides from Sequence Data.

Journal of chemical information and modeling·2026
Same author

Design of permeability-optimized target-binding macrocycles <i>via</i> direct preference optimization.

Chemical science·2026
Same author

Bridging Generative AI and Diffusion Models With Molecular Simulation to Design Anti-Quorum-Sensing De novo Peptides Targeting LasR of Pseudomonas aeruginosa.

Probiotics and antimicrobial proteins·2026
Same author

Prosta-omics: machine learning-driven TPSA prediction and molecular modeling of ASPM-inhibitors for prostate cancer treatment.

Molecular diversity·2026
Same author

Correction: Microsecond simulations to investigate the structural mechanism of super-resistant double mutations in BTK to the covalent inhibitor ibrutinib in multiple leukemia.

Scientific reports·2026
Same author

WGX-50 Promotes Healthy Ageing in Caenorhabditis elegans: A Combined Computational and Experimental Study.

Chemical biology & drug design·2025
Same journal

PSDTA: An Approach to Drug-Target Binding Affinity Prediction by Integrating Physicochemical and Structural Information to Reduce Feature Redundancy.

Journal of chemical information and modeling·2026
Same journal

M-JEPA: Predictive Self-Supervised Learning for Molecular Graphs with Scaffold-Shift Evaluation on Tox21.

Journal of chemical information and modeling·2026
Same journal

Advancing Biochemical Molecule Registration, Representation and Search for New Drug Modalities.

Journal of chemical information and modeling·2026
Same journal

A Unified Molecular Graph and Protein Language Model Framework for Predicting Human Drug-Hormone Receptor Interactions with Structure-Aware Validation.

Journal of chemical information and modeling·2026
Same journal

Intricate Role of Cholesterol in Membrane Fusion.

Journal of chemical information and modeling·2026
Same journal

tmGNN-XAI: An Explainable Graph Neural Network Tool for Predicting Electronic Properties of Transition Metal Complexes from SMILES.

Journal of chemical information and modeling·2026
See all related articles

Related Experiment Video

Updated: Jul 9, 2025

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.9K

A Multimodal Deep Learning Framework for Predicting PPI-Modulator Interactions.

Heqi Sun1, Jianmin Wang2, Hongyan Wu3

  • 1State Key Laboratory of Microbial Metabolism, Shanghai-Islamabad-Belgrade Joint Innovation Center on Antibacterial Resistances, Joint International Research Laboratory of Metabolic & Developmental Sciences and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China.

Journal of Chemical Information and Modeling
|December 1, 2023
PubMed
Summary
This summary is machine-generated.

A new deep learning framework, MultiPPIMI, accurately predicts protein-protein interaction (PPI) modulators using only sequence data. This method aids in discovering novel drug targets for diseases by overcoming limitations of existing computational approaches.

More Related Videos

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.6K
Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K

Related Experiment Videos

Last Updated: Jul 9, 2025

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.9K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.6K
Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K

Area of Science:

  • Computational biology
  • Bioinformatics
  • Drug discovery

Background:

  • Protein-protein interactions (PPIs) are crucial for biological functions and disease development.
  • Current computational methods for identifying PPI modulators often require target structures or known modulators, limiting their use for novel targets.
  • There is a need for versatile computational tools to predict PPI modulators applicable to new targets.

Purpose of the Study:

  • To develop a novel sequence-based deep learning framework, MultiPPIMI, for predicting interactions between protein targets and modulators.
  • To address the limitations of existing methods in identifying modulators for novel PPI targets.
  • To provide a computational tool that can assist in the screening of potential therapeutic agents targeting PPIs.

Main Methods:

  • Developed MultiPPIMI, a sequence-based deep learning framework.
  • Integrated multimodal representations of PPI targets and modulators.
  • Employed a bilinear attention network to capture intermolecular interactions.
  • Evaluated performance on a curated benchmark dataset using AUROC metrics in cold-start and random-split scenarios.

Main Results:

  • MultiPPIMI achieved an average AUROC of 0.837 in three cold-start scenarios, demonstrating effectiveness for novel targets.
  • Achieved an AUROC of 0.994 in the random-split scenario, indicating high accuracy.
  • A case study demonstrated MultiPPIMI's utility in screening inhibitors for Keap1/Nrf2 PPI interactions, aiding molecular docking simulations.

Conclusions:

  • MultiPPIMI offers a promising sequence-based deep learning approach for predicting PPI modulators.
  • The framework effectively handles novel PPI targets without requiring structural information or reference modulators.
  • MultiPPIMI can serve as a valuable tool to accelerate the discovery and screening of modulators for therapeutic PPIs.